← 홈

전체 프로그램

ADC 1032 · Antibody 4683 · CGT 2713 · 다음 갱신 D-7 · 마지막 7월 21일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 3,526개
AntibodystaleDiwakar DavarPhase 2

Domvanalimab (Domvanalimab)

Melanoma · Metastatic Urothelial Cancer

#MetastaticUrothelialCancer#Antibody#Phase2#항체#면역항체+3
임상시험 22상태 RECRUITING
ADCBiologicstaleMerck Sharp & Dohme LLCPhase 2

HER3-DXd (HER3-DXd)

Carcinoma, Non-Small-Cell Lung · HER3

#HER3#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
효능 ORR 56%임상시험 22상태 RECRUITING
ADCBiologicstaleHansoh BioMedical R&D CompanyPhase 2

HS-20093 (HS-20093)

Advanced Solid Tumor · Metastatic Colorectal Cancer (CRC)

#MetastaticColorectalCancerCRC#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 22상태 RECRUITING
CGTBiologicstaleNanjing Legend Biotech Co.Phase 2

LCAR-B38M CAR-T Cell (LCAR-B38M CAR-T Cell)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#CGT#Phase2#세포유전치료#CAR-T+2
효능 ORR 96.6%임상시험 22상태 DISCONTINUED
AntibodystaleRegeneron PharmaceuticalsPhase 2

Linvoseltamab (Linvoseltamab)

Food Allergy · Multiple Myeloma

#MultipleMyeloma#Antibody#Phase2#항체#면역항체+3
임상시험 22상태 RECRUITING
ADCBiologicstaleAstraZenecaPhase 1

MEDI5752 (MEDI5752)

Advanced or Metastatic NSCLC · Advanced or Metastatic NSCLC

#AdvancedorMetastaticNSCLC#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 22상태 RECRUITING
AntibodystaleAstraZenecaPhase 2

Monalizumab (Monalizumab)

Non-small Cell Lung Cancer · Non-small Cell Lung Cancer

#Non-smallCellLungCancer#Antibody#Phase2#항체#면역항체+2
효능 ORR 23.9%임상시험 22상태 RECRUITING
ADCBiologicstaleInstitut du Cancer de Montpelli…Phase 1

TDM1 (TDM1)

HER2-positive Breast Cancer · HER2

#HER2#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
효능 ORR 9.3%임상시험 22상태 ACTIVE
ADCBiologicstaleDualityBio Inc.Phase 2

BNT327 (BNT327)

Solid Tumors · Solid Tumors

#SolidTumors#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 21상태 RECRUITING
ADCBiologicstaleCelgenePhase 2

CC-99282 (CC-99282)

Lymphoma, Non-Hodgkin; Lymphoma, Large B-Cell, Diffuse · Non-Hodgkin Lymphoma

#Non-HodgkinLymphoma#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
효능 ORR 92.9%임상시험 21상태 RECRUITING
ADCBiologicstaleInnovent Biologics (Suzhou) Co.…Phase 2

IBI363 (IBI363)

Rare Malignant Neoplasm; Advanced Solid Tumors · Rare Malignant Neoplasm

#RareMalignantNeoplasm#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 21상태 RECRUITING
CGTBiologicstaleShanghai Yunying Medical Techno…Phase 1

R130 (Recombinant oncolytic herpes simplex virus type 1, Recombinant oncolytic herpes simplex virus type 1 (R130))

Lung Cancer; Bronchial Cancer · Sarcoma

#Sarcoma#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 21상태 ACTIVE
CGTBiologicstaleLion TCR Pte. Ltd.Phase 1

TCR redirected T cells (TCR redirected T cells)

Hepatocellular Carcinoma · Hepatocellular Carcinoma

#HepatocellularCarcinoma#CGT#Phase1#세포유전치료#CAR-T+2
효능 ORR 15%임상시험 21상태 ACTIVE
AntibodystaleJanssen Research & Development,…Phase 2

Cetrelimab (Cetrelimab)

Carcinoma, Non-Small-Cell Lung · Neoplasms

#Neoplasms#Antibody#Phase2#항체#면역항체+4
효능 ORR 75%임상시험 20상태 RECRUITING
CGTBiologicstaleCelgenePhase 3

JCAR017 (JCAR017)

Lymphoma, Non-Hodgkin; Lymphoma, Large B-Cell, Diffuse · Precursor Cell Lymphoblastic Leukemia-Ly

#PrecursorCellLymphoblasticLeukem#CGT#Phase3#세포유전치료#CAR-T+4
효능 ORR 92.9%임상시험 20상태 ACTIVE
ADCBiologicstaleRisen (Suzhou) Pharma Tech Co.,…Preclinical

Pyrotinib Maleate Tablets (Pyrotinib Maleate Tablets)

HER2+ Advanced Breast Cancer Patients Progressing on TKI Therapy · HER2

#HER2#ADC#Preclinical#항체약물접합체#antibody-drug-conjugate+2
임상시험 20상태 ACTIVE
ADCBiologicstaleDanish Breast Cancer Cooperativ…Phase 3

Ribociclib with ET (Ribociclib with ET)

Metastatic Breast Cancer; ER-positive Breast Cancer · HER2

#HER2#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+3
임상시험 20상태 DISCONTINUED
AntibodystaleJanssen Research & Development,…Phase 2

Bermekimab (Bermekimab)

Dermatitis, Atopic · Hidradenitis Suppurativa

#HidradenitisSuppurativa#Antibody#Phase2#항체#면역항체+4
효능 ORR 0%임상시험 19상태 DISCONTINUED
CGTBiologicstaleChongqing Precision Biotech Co.…Phase 2

CEA-targeted CAR-T cells (CEA-targeted CAR-T cells)

Gastric Cancer; Colon Cancer · CEA

#CEA#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 19상태 ACTIVE
ADCBiologicstaleEli Lilly and CompanyPhase 2

Olutasidenib (Olutasidenib)

Acute Myeloid Leukemia; Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm · Acute Myeloid Leukemia

#AcuteMyeloidLeukemia#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
효능 ORR 2%임상시험 19상태 RECRUITING

37 / 177 페이지

← 이전다음 →